# The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT

> **NCT03123679** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** pulmonary perfusion/reserve with Tc-99m-MAA SPECT/ Low dose CT

## Key facts

- **NCT ID:** NCT03123679
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-10
- **Primary completion:** 2019-04-02
- **Final completion:** 2020-04-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03123679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03123679, "The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03123679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*